GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant]
offering product urn:matchory:offering:01m772jz07fhn9g94rtt5nn4tf
Offered by Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity). Relation: not stated. Commodity: 51201600 Vaccines and antigens and toxoids (class).
An offering's identity is its owner, its commodity and its normalised name; it is never merged with another supplier's.
Facts
| Attribute | Value as written | Producer | Evidence | Observed | Status |
|---|---|---|---|---|---|
| Name as stated name | GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] | products products 2 | GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant]https://www.merck.com/products/ |
2026-11-12 | current |
| Name as stated name | GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] | extraction extract 3 | GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant]https://www.merck.com/products/ |
2026-11-12 | current |
| UNSPSC classification unspsc | 51201600 (16 candidates considered) (0.94) | classification unspsc 3 | 2026-11-12 | current |